HomePeptides › GHK-Cu

GHK-Cu

Copper tripeptide-1

Tier 3 · Limited Human Data
Class
Copper-binding tripeptide
Molecular target
Copper transport; matrix remodelling
Sequence / structure
Gly-His-Lys · Cu(II)
Evidence tier
Tier 3 — Limited Human Data
Category
Tissue Repair & Cytoprotection
Emergency card
Signs something is wrong

Any new or unusual symptom after dosing. Because this compound has little or no human safety data, there is no established list of 'expected' effects to reassure you against — treat anything abnormal as a signal.

What to do now

Stop at the first clearly abnormal reaction and reassess. Keep the vial and lot number in case you need to describe what you actually took.

When it is an emergency

Any severe or fast-worsening symptom — difficulty breathing, chest pain, fainting, severe pain — is a 911 call regardless of the compound.

Any injection — every time

Allergic reaction: hives, swelling of the lips, tongue or throat, wheezing or dizziness can escalate to anaphylaxis within minutes — call 911 immediately. Site infection: spreading redness, heat, swelling, pus or fever is not wait-and-see; an abscess or cellulitis can need drainage or IV antibiotics. Unverified product: grey-market vials are frequently mislabelled or contaminated, so a reaction may be to endotoxin or the wrong contents, not the named compound.

This is not permission or instruction to use this compound. It is harm-reduction information for someone who has already decided to, so that a bad reaction is recognised and treated. When in doubt, get help — embarrassment is survivable.

Biology & mechanism

A tripeptide with exceptionally high affinity for copper(II). GHK occurs naturally in plasma and declines with age. The copper complex modulates expression of a broad set of genes involved in extracellular matrix remodelling, and stimulates collagen and glycosaminoglycan synthesis in dermal fibroblasts. Copper delivery appears central to the activity.

What the research actually shows

The best-supported member of the repair group, and specifically for topical cosmetic use. Controlled studies report improvements in skin appearance, dermal thickness, and photodamage measures. Widely used in commercial skincare. Evidence for systemic or injected use is not comparable.

Regulatory status

Used as a cosmetic ingredient in the US, which requires no FDA pre-approval. Not an FDA-approved drug. Cosmetic status covers topical appearance claims only — not therapeutic or systemic use.

Safety signals

Topical use has a long commercial record and is generally well tolerated. Injected use raises copper-loading considerations and is not supported by the cosmetic evidence base.

Clinical trial dosing — what the studies actually used

Topical cosmetic formulations (low percentages) have controlled data for skin appearance. No injected human dose has been established.

Reported from clinical trials or FDA labelling as a matter of record. It is not a recommendation, and for unapproved compounds no dose has been shown safe or effective in humans.

We report study doses, not protocols

Above is what was administered in trials or on FDA labels, reported as fact. We do not convert it into a personal protocol, calculate a dose for your body weight, or tell you what to inject or how to reconstitute it — that decision belongs with a licensed physician. See our editorial policy.

References & further reading

Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.

Important notice Forge Bioenergy publishes scientific reference information only. Nothing on this site is medical advice, a therapeutic claim, or a recommendation to use any substance in humans. Many peptides described here are not approved by the FDA for any use, and several are approved only for narrow indications under prescription. We do not publish dosing, administration, or usage protocols. Consult a licensed physician before making any medical decision.